CHOICE

Our aim is to compare home versus in-hospital cervical ripening to determine whether home cervical ripening is within an acceptable margin of in-hospital cervical ripening for the safety outcome of neonatal unit (NNU) admission, whether it is more acceptable to women and whether it is cost-effective from both NHS and patient perspectives.    

Chief Investigator:  Dr Sarah Stock 

Image

Number and location of participating sites / geographical scope (by region/ country):  Expected 30 sites (18 sites open, 5 in set up)

EudraCT number: N/A

ISRCTN number: 32652461

Funder:  NIHR HTA  

Start and End date

Of grant award: 01/12/2019 - 30/11/2022

Of recruitment: Ongoing

Current status: In recruitment

Website: https://choicestudy.co.uk/

Email: CHOICE.Study@ed.ac.uk

UK GDPR Privacy Statement: If you have participated in this study and would like to read how it complies with UK GDPR, please read this document.

Chief Investigator: 

Dr Sarah Stock, Usher Institute of Population Health Sciences and Informatics, NINE Edinburgh BioQuarter, 9 Little France Road, Edinburgh, EH16 4UX   

Trial Manager: CHOICE.Study@ed.ac.uk

ECTU Involvement:  Trial Management, Statistics, Data Management